Lisa Lawrence
Psychiatry · Cleveland, OHNPI 1821127747
Payments from drug & device makers
Across 132 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$477
- Lundbeck LLC$436
- AbbVie$291
- Johnson & Johnson$184
- Indivior Inc.$159
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$131
- plus $416 from 9 others
What the payments were for
- Food & beverage$2,05298%
- Education$412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 30 | $477 |
| Lundbeck LLC | 26 | $436 |
| AbbVie(2 entities) | 18 | $291 |
| Johnson & Johnson | 12 | $184 |
| Indivior Inc. | 11 | $159 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $131 |
| Alkermes, Inc. | 8 | $116 |
| Vanda Pharmaceuticals Inc. | 4 | $80 |
| Sunovion Pharmaceuticals Inc. | 4 | $68 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $40 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Neurocrine Biosciences, Inc. | 1 | $25 |
| Shire North American Group Inc | 1 | $14 |
| Neuronetics, Inc. | 1 | $12 |
How this compares
$2,093 in reported general payments places this provider in the 80th percentile of 1,119 psychiatry providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 16 | $33,906 |
| RexultiBrexpiprazole | 23 | $32,980 |
| VraylarCariprazine Hcl | 19 | $27,779 |
| Risperidone ErRisperidone Microspheres | 24 | $23,560 |
| TrintellixVortioxetine Hydrobromide | 24 | $11,464 |
| Aripiprazole | 122 | $6,269 |
| Fluphenazine Hcl | 64 | $5,297 |
| AdderallDextroamphetamine/Amphetamine | 11 | $3,650 |
| Lurasidone Hcl | 67 | $3,411 |
| Hydroxyzine Hcl | 82 | $3,052 |
| Divalproex Sodium ErDivalproex Sodium | 60 | $2,969 |
| Buspirone Hcl | 179 | $2,814 |
| Bupropion XlBupropion Hcl | 190 | $2,662 |
| Quetiapine Fumarate | 172 | $2,637 |
| Haloperidol Decanoate | 51 | $2,550 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $477 | $66,88639 claims |
| AbbVieVraylar | $291 | $27,77919 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Adderall | $40 | $15,11435 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Cleveland
- Binit ShahCleveland$913K
- Rajeet ShresthaCleveland$537K
- Martha SajatovicCleveland$404K
- Joseph CalabreseCleveland$82K
- Ketan DeorasCleveland$80K
- Keming GaoCleveland$76K
- Aaron VazquezCleveland$55K
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.